CINECA IRIS Institutional Research Information System

MORNESE PINNA, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.607
EU - Europa 1.155
AS - Asia 730
SA - Sud America 432
AF - Africa 53
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.002
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.533
IT - Italia 451
CN - Cina 237
PE - Perù 213
SG - Singapore 153
IE - Irlanda 105
FR - Francia 99
ES - Italia 95
TR - Turchia 89
AR - Argentina 88
SE - Svezia 88
CL - Cile 73
DE - Germania 70
AT - Austria 49
MX - Messico 49
GB - Regno Unito 40
IN - India 35
VN - Vietnam 33
ID - Indonesia 30
BE - Belgio 26
JP - Giappone 24
BR - Brasile 23
AU - Australia 21
CA - Canada 21
IR - Iran 20
NL - Olanda 20
RO - Romania 19
BO - Bolivia 16
SA - Arabia Saudita 16
HK - Hong Kong 15
FI - Finlandia 14
JO - Giordania 13
MA - Marocco 13
ZA - Sudafrica 13
CO - Colombia 12
GR - Grecia 12
UA - Ucraina 12
RU - Federazione Russa 11
TN - Tunisia 11
PL - Polonia 10
CZ - Repubblica Ceca 8
LB - Libano 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
KZ - Kazakistan 7
TH - Thailandia 7
CH - Svizzera 6
KR - Corea 6
EG - Egitto 5
SY - Repubblica araba siriana 5
UG - Uganda 5
EU - Europa 4
HR - Croazia 4
SI - Slovenia 4
CR - Costa Rica 3
MD - Moldavia 3
MN - Mongolia 3
PY - Paraguay 3
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
NG - Nigeria 2
PS - Palestinian Territory 2
TG - Togo 2
TW - Taiwan 2
UY - Uruguay 2
AN - Antille olandesi 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
LI - Liechtenstein 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
Totale 4.002
Salva come PNG Salva come JPEG
Città #
Chandler 293
Lima 145
Singapore 130
Dublin 104
Fairfield 79
Santa Clara 70
Torino 69
Beijing 64
Turin 61
Ashburn 60
Woodbridge 54
Ann Arbor 50
Nyköping 50
Houston 42
Milan 42
Santiago 40
Vienna 40
Columbus 39
Wilmington 39
Medford 31
Dearborn 30
New York 29
Princeton 26
Redwood City 26
Cambridge 24
Jakarta 24
Paris 24
Villeurbanne 23
Istanbul 22
San Miguel de Tucumán 22
Barcelona 19
Guangzhou 18
Rome 18
Ankara 17
Brussels 17
Seattle 16
Arequipa 15
Huancayo 15
Madrid 15
Bucharest 13
Buenos Aires 13
Federal 13
Pisa 12
Dong Ket 11
La Paz 11
Mexico City 11
Boardman 10
Chengdu 10
San Diego 10
Fremont 9
Hangzhou 9
Hebei 9
Jacksonville 9
Konya 8
Lima region 8
Omaha 8
Riyadh 8
Warsaw 8
Bari 7
Brno 7
Delhi 7
Helsinki 7
Hong Kong 7
Naples 7
Osorno 7
Padova 7
Pavia 7
Thessaloniki 7
Angers 6
Buffalo 6
Cape Town 6
Heverlee 6
Innsbruck 6
Kansas City 6
Nanjing 6
Pozzolo Formigaro 6
Shanghai 6
Tashkent 6
Toronto 6
Trujillo 6
Upper Marlboro 6
Bogotá 5
Boston 5
Córdoba 5
Munich 5
Nagoya 5
Norwalk 5
Porto Alegre 5
Sesto San Giovanni 5
Stuttgart 5
Valencia 5
Vigevano 5
Washington 5
Amman 4
Astana 4
Bariloche 4
Bengaluru 4
Berlin 4
Chicago 4
Concorezzo 4
Totale 2.328
Salva come PNG Salva come JPEG
Nome #
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review 1.384
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients 352
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 178
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? 151
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis 141
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients 130
Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study 112
Role of simeprevir plasma concentrations in HCV treated patients with dermatological symptoms 101
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 101
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs 100
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia 85
Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry 83
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 81
Daclatasvir Plasma Levels in a Cohort of Patients with Hepatitis C Virus Infection Taking Methadone: A Prospective Analysis 74
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy 72
Antibiotic de-escalation experience in the setting of emergency department: A retrospective, observational study 71
Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study 70
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 67
New cephalosporins for the treatment of pneumonia in internal medicine wards 66
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study 62
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 61
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy 59
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: a prospective study 58
Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: A case series 54
Impact of an empiric antimicrobial therapy manual on antimicrobial usage and multidrug resistant organism trends in a large Italian teaching hospital 53
JC virus DNA in cerebrospinal fluid: insight into clinical significance 48
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens 45
Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key? 39
Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN) 36
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series 26
Epidemiology and Risk Factors for Nosocomial Infections in Left Ventricular Assist Device Recipients 25
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality 21
The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards 19
Nodular Cutaneous Lesions in Immune-Compromised Hosts as a Clue for the Diagnosis of Disseminated Nocardiosis: From Bedside to Microbiological Identification 17
Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review 16
Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience 15
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient 13
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic 13
Predictors of mortality in patients with COVID-19 infection in different health-care settings: A retrospective analysis from a CORACLE study group 12
Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS) 11
Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry 8
null 2
Totale 4.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.497
article - articoli 0
book - libri 0
conference - conferenze 336
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 9 45 19 11 15 82 10 9
2020/2021216 6 12 10 6 11 20 2 8 8 39 33 61
2021/2022584 35 44 34 33 36 54 43 20 39 57 105 84
2022/20231.166 74 70 50 108 93 199 61 118 128 61 119 85
2023/2024896 99 110 47 51 98 92 61 72 21 97 81 67
2024/2025575 51 81 129 127 187 0 0 0 0 0 0 0
Totale 4.132